Rapid Antimicrobial Susceptibility Testing: A Key for Managing Antimicrobial Resistance
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 31 July 2024 | Viewed by 2494
Special Issue Editors
2. Food Hygiene and Control, Faculty of Veterinary Medicne, South Valley University, Qena, Egypt
Interests: antibiotic resistance; one health; rapid diagnostics; susceptibility testing; gram negatives; genomics
Special Issues, Collections and Topics in MDPI journals
2. Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University of Seville, Seville, Spain
Interests: multidrug resistance; clinical pathogens; antimicrobial susceptibility testing; gram negatives; genomics
Special Issue Information
Dear Colleagues,
Choice of therapeutics for treating multidrug-resistant bacteria (MDR)-associated infections is mainly based on the result of susceptibility testing performed using different techniques. The delayed detection of resistance results in delayed administration of efficient antibiotic therapy, clinical treatment failure, or hinders the isolation of MDR carriers, thereby promoting outbreaks. Therefore, the development of rapid, easy-to-perform, cost-effective and accurate diagnostics of MDR bacteria in infected or colonized patients is a matter of high priority in clinical microbiology, as it has the potential to improve patient management, limit the dissemination of MDR isolates, and assist in clinical decision-making.
In this Special Issue, we aim to highlight the current state of art in rapid diagnostics for antimicrobial resistance, alternatives to traditional AST methods as well as recent advancements in new diagnostics systems. We invite authors to submit articles focused on topics including, but not limited to, the following:
- Modified and new phenotypic techniques to detect antimicrobial resistant pathogens;
- Genotypic techniques for the rapid diagnosis of AMR;
- Novel rapid diagnostic tests for AMR;
- Novel biomarkers to detect AMR pathogens;
- Evaluation of novel diagnostic methods;
- Evaluation of commercially available rapid diagnostics for AMR.
Dr. Mustafa Sadek
Dr. José Manuel Ortiz De La Rosa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidrug-resistant bacteria
- rapid diagnostics
- susceptibility testing
